list of glp-1 drugs for weight loss glp 1 oral Market Overview: Agonists and the Obesity Market GLP-1 Weight-Loss Drugs Could Address

Melanie Jay, who studies the treatment and prevention of obesity at NYU Langone Health

doi: 10.1016/j.cgh.2024.03.006

The main concerns with GLP-1 agonist drugs include: GI side effects (nausea, diarrhea, vomiting, constipation, abdominal pain) High out-of-pocket cost for those who do not quality under insurance Risk of inadequate nutrition (reduced intake + insufficient nutrition counseling) Significant loss of muscle mass & bone density High discontinuation rates (with lost weight regained) Limited public & clinician knowledge on importance/implementation of nutrition and lifestyle changes Side Effects and Costs of GLP-1 Medications The use of GLP-1 drugs has been associated with numerous side effects, ranging from mild to severe

In-class differences were noticed especially related to heart failure (HF) and are discussed later in this manuscript

McGraw-Hill / Lange Meier JJ (2012): GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

Regarding the secondary endpoint hospitalization due to heart failure, the results of the studies are heterogenous